ACVR2A and pulmonary arterial hypertension: Research has unraveled the role of transforming growth factor β (TGF-β) super-family members, including activin receptor type IIA (ActRIIA), ActRIIA ligands activin A, activin B, and others in the development of PAH [7-9].